Tweenvest Stocks

Baudax Bio, Inc. (OTCPK: BXRX.Q)

Health Care · Pharmaceuticals · US

$0.00

— today · 0.0% 1Y

Baudax Bio, Inc. (OTCPK: BXRX.Q) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $52.00 and employs 9 people.

Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.

Tweenvest scores Baudax Bio, Inc. across four factors: quality 12/100, value 38/100. Its strongest factor is value.

BXRX.Q price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$52.00
Revenue (TTM)
$1.27M
P/E
—
EPS
-1.91
Dividend yield
—
Beta (5Y)
-27.18
52-week high
$0.00
52-week low
$0.00
Avg volume (3M)
—
Shares outstanding
52.46M
Employees
9
Next earnings
—

About Baudax Bio, Inc.

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMBA, which is in phase I clinical trial; BX3000, an NMBA reversal agent; and Dex-IN, a proprietary intranasal formulation of dexmedetomidine. The company was incorporated in 2019 and is based in Malvern, Pennsylvania.

ISIN
US07160F4046
Founded
2015
Listed since
Nov 14, 2019
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Indigenous Bloom Hemp Corp.OTCPK: VRTH.F$71.00$0.00—
Stem Holdings, Inc.OTCPK: STMH$67.00$——
North Bud Farms Inc.OTCPK: NOBD.F$67.00$——
Iterum Therapeutics plcOTCPK: ITRM.F$53.00$——
Core One Labs Inc.OTCPK: CLAB.F$47.00$0.00—
Claritas Pharmaceuticals, Inc.OTCPK: CLAZ.F$38.00$0.00—
Maven Brands Inc.OTCPK: TRLF.F$35.00$0.00—
Intellipharmaceutics International Inc.OTCPK: IPCI.Q$33.00$——

Browse every Pharmaceuticals company →

Figures last refreshed Oct 4, 2026.